Derivatives of partially desulphated glycogaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect

Details for Australian Patent Application No. 2001292231 (hide)

International Classifications

Event Publications

19 June 2003 Application Open to Public Inspection

Published as AU-B-2001292231

14 February 2008 Assignment before Grant

Sigma-Tau Industrie Farmaceutiche Riunite S.p.A The application has been assigned to Sigma-Tau Research Switzerland S.A 2002

5 June 2008 Application Accepted

Published as AU-B-2001292231

2 October 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.